Oleocanthal-based solution to reduce salty taste perception in electrolyte beverages

Overview

Excess sodium intake is linked to cardiovascular disease, yet many functional and electrolyte beverages require salt for hydration and electrolyte balance. This research investigates the use of oleocanthal, a naturally occurring phenolic compound in extra virgin olive oil, as a sensory additive that reduces perceived saltiness. The approach targets TMC4, a recently identified human salt taste receptor, using oleocanthal's potential inhibitory action to allow formulators to lower sodium content without sacrificing taste. If validated, this could benefit sports drinks, medical rehydration solutions, and reduced-sodium food and beverage products.

Technical specifications

The proposed work is based on the hypothesis that compounds acting as agonists of the TRPA1 receptor may inversely inhibit TMC4, the primary human salt receptor. Key technical elements include:

• TMC4 expression constructs introduced into HEK293 cells or human fungiform taste cells
• Whole-cell patch-clamp electrophysiology to measure ion channel activity
• Calcium imaging to assess intracellular signaling responses
• Testing across varying pH conditions (below pH 5.5, known to inhibit TMC4)
• Evaluation of oleocanthal combined with NaCl, with and without sweeteners, since moderate sweetness may further suppress salt perception
• Measurement of ATP release as a downstream taste signaling marker
• Comparison with other plant-derived TRPA1 agonists such as cinnamaldehyde and piperine
• Pharmacological confirmation in mice and human sensory studies

Technology readiness level

This research is at an early discovery stage (TRL 2–3). The scientific rationale is grounded in published evidence that ibuprofen inhibits TMC4 currents and that oleocanthal shares key pharmacological properties with ibuprofen, including TRPA1 activation and COX enzyme effects. Validation work will begin with cell-based assays using overexpressed TMC4, followed by animal studies and eventual human sensory testing. Successful validation would establish proof-of-concept for oleocanthal as a functional beverage additive for salt reduction.